FDA Says These Are "Drugs Of Dubious Origin, Safety, And Efficacy"
In mid-December 2005 the FDA reported that the majority of Web sites believed to be Canadian pharmacies selling prescription drugs manufactured in Canada are actually "fronts" for drugs that were not manufactured in Canada and, in fact, came from 27 different countries.
In August 2005 the FDA conducted an inspection of packages containing prescription drugs ordered online by U.S. patients that were shipped through John F. Kennedy International Airport in New York, Miami International Airport, and Los Angeles International Airport.
According to a December 20, 2005 article in The Wall Street Journal:
"Out of nearly 4,000 parcels examined, almost 1,700, or 43%, had been ordered from ‘Canadian’ Internet pharmacies and were represented as being of Canadian origin. Of the 1,700 packages, 85% of the drugs weren’t manufactured in Canada and came from 27 different countries."
In more detail, the agency identified India, Israel, Costa Rica, and Vanuatu as the four countries which appeared to be the primary sources of those drugs that were ordered online from pharmacies alleged to be Canadian in origin.
In a December 16, 2005 statement Andrew von Eschenbach, the FDA’s acting commissioner, commented:
- "This operation suggests that drugs ordered from so-called Canadian Internet sites are not drugs of known safety and efficacy."
- "These results make clear there are Internet sites that claim to be ‘Canadian’ that, in fact, are peddling drugs of dubious origin, safety and efficacy."
As is well-known by now, many consumers order prescription drugs from Canada because they usually cost less than those sold in the U.S. The FDA, however, has long warned patients in the U.S. not to order prescription drugs online from Canada or other foreign countries for the very reasons stated by Dr. von Eschenbach.
In addition to having been falsely promoted as being of Canadian origin, the FDA found that some of the prescription drug products were counterfeit — an even more alarming problem for patients.
The FDA said it is working with Canadian drug regulators and law-enforcement authorities on the matter.
(Posted by: Tom Lamb)
Leave a Reply